2
|
Mohamed AA, El-Toukhy N, Ghaith DM, Badawy I, Abdo SM, Elkadeem M, Mahrous MN, Abd-Elsalam S. Talin-1 Gene Expression as a Tumor Marker in Hepatocellular Carcinoma Patients: A Pilot Study. ACTA ACUST UNITED AC 2020. [DOI: 10.2174/1875318302010010015] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Background & Aims:
Hepatocellular Carcinoma (HCC) is the most common primary liver tumor. It is the second most common cancer in men and the sixth in women in Egypt. One of the proteins participating in the trans-endothelial migration is Talin-1. It also has a role in the formation and metastasis of different types of cancer. This study aimed to evaluate the diagnostic impact of Talin-1 gene expression in HCC Egyptian patients.
Methods:
Our study included forty HCC patients, thirty liver cirrhosis patients without HCC and thirty healthy subjects. For all groups, clinical and biochemical parameters were investigated. Tumor characteristics were assessed and tumor staging was done using Okuda, CLIP, VISUM and Tokyo staging systems. In addition, Serum Alpha-Fetoprotein (AFP) levels were assayed using Enzyme Immunoassay (EIA) and Talin-1 gene expression was assessed in the Peripheral Blood Mononuclear Cells (PBMCs) via quantitative real-time Polymerase Chain Reaction (PCR).
Results:
Talin-1 gene expression was significantly upregulated in HCC patients in comparison to cirrhotic and control subjects. The Receiver Operating Characteristic (ROC) analysis indicated that Talin-1 gene expression surpasses serum levels of AFP in the diagnosis of HCC. In particular, the cut off value of 9.5 (2-∆∆Ct) recorded an AUC of 85.7% with a sensitivity of 93.3% and specificity of 80%.
Conclusion:
Our data confirmed an évident diagnostic role of Talin-1 gene expression for HCC detection.
Collapse
|
3
|
Hao G, Zhai J, Jiang H, Zhang Y, Wu M, Qiu Y, Fan C, Yu L, Bai S, Sun L, Yang Z. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling. Biomed Pharmacother 2020; 122:109677. [PMID: 31810012 DOI: 10.1016/j.biopha.2019.109677] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Revised: 11/05/2019] [Accepted: 11/13/2019] [Indexed: 12/18/2022] Open
Abstract
Acetylshikonin, a natural naphthoquinone derivative compound from Lithospermum erythrorhyzon, has been reported to kill bacteria, suppress inflammation, and inhibit tumor growth. However, the effect of acetylshikonin on human chronic myelocytic leukemia (CML) cells apoptosis and its detailed mechanisms remains unknown. The purpose of the present study was to investigate whether acetylshikonin could inhibit proliferation or induce apoptosis of the K562 cells, and whether by regulating the NF-κB signaling pathway to suppress the development of CML. K562 cells were treated with serial diluted acetylshikonin at different concentrations. Our data showed that K562 cell growth was significantly inhibited by acetylshikonin with an IC50 of 2.03 μM at 24 h and 1.13 μM at 48 h, with increased cell cycle arrest in S-phase. The results of annexin V-FITC/PI and AO/EB staining showed that acetylshikonin induced cell apoptosis in a dose-dependent manner. K562 cells treated with acetylshikonin underwent massive apoptosis accompanied by a rapid generation of reactive oxygen species (ROS). Scavenging the ROS completely blocked the induction of apoptosis following acetylshikonin treatment. The levels of the pro-apoptotic proteins Bax, cleaved caspase-9, cleaved PARP and cleaved caspase-3 increased with increased concentrations of acetylshikonin, while the level of the anti-apoptotic protein Bcl-2 was downregulated. The levels of Cyt C and AIF, which are characteristic proteins of the mitochondria-regulated intrinsic apoptotic pathway, also increased in the cytosol after acetylshikonin treatment. However, the mitochondrial fraction of Cyt C and AIF were decreased under acetylshikonin treatment. In addition, acetylshikonin decreased Bcr-Abl expression and inhibited its downstream signaling. Acetylshikonin could lead to a blockage of the NF-κB signaling pathway via decreasing nuclear NF-κB P65 and increasing cytoplasmic NF-κB P65. Moreover, acetylshikonin significantly inhibited the phosphorylation of IkBα and IKKα/β in K562 cells. These results demonstrated that acetylshikonin significantly inhibited K562 cell growth and induced cell apoptosis through the mitochondria-regulated intrinsic apoptotic pathway. The mechanisms may involve the modulating ROS accumulation, inhibition of NF-κB and BCR-ABL expression. The inhibition of BCR-ABL expression and the inactivation of the NF-κB signaling pathway caused by acetylshikonin treatment resulted in K562 cell apoptosis. Together, our results indicate that acetylshikonin could serve as a potential therapeutic agent for the future treatment of CML.
Collapse
Affiliation(s)
- Gangping Hao
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China.
| | - Jing Zhai
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Hanming Jiang
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Yuanying Zhang
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Mengdi Wu
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Yuyu Qiu
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Cundong Fan
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Lijuan Yu
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Suyun Bai
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Lingyun Sun
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China
| | - Zhongfa Yang
- School of Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong, China; Institute of Clinical Medicine, Weifang Medical University, Weifang, Shandong, China.
| |
Collapse
|
4
|
Nandi S, Chandra S, Sikder R, Bhattacharya S, Ahir M, Biswal D, Adhikary A, Pramanik NR, Lai TK, Drew MGB, Acharya K. Characterization and Inception of a Triterpenoid Astrakurkurol, as a Cytotoxic Molecule on Human Hepatocellular Carcinoma Cells, Hep3B. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2019; 67:7660-7673. [PMID: 31250646 DOI: 10.1021/acs.jafc.9b01203] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Mushrooms are customary influential sources of pharmaceutically active metabolites. Usually lanostane-type triterpenoids from mushrooms had prospective for cancer disease treatments. Recently, a triterpenoid, astrakurkurol obtained from the fresh basidiocarps of the edible mushroom Astraeus hygrometricus, drew attention as a new cytotoxic therapeutic. The structural stability of this triterpenoid had been established with the amalgamation of density functional theory (DFT) calculations and study of single-crystal X-ray diffraction. To successfully manifest astrakurkurol as a potent cytotoxic therapeutics, a wide apprehension on the molecular and cellular mechanisms underlying their action is prerequisite. On this account, our study was directed to scrutinize the influence of this triterpenoid on human hepatocellular cancer cell model Hep3B. Encapsulating all experimental facts revealed that astrakurkurol had significantly decreased cell viability in a concentration-dependent manner. This effect was unveiled to be apoptosis, documented by DNA fragmentation, chromatin condensation, nuclear shrinkage, membrane blebing, and imbalance of cell cycle distribution. Astrakurkurol persuaded the expression of death receptor associated proteins (Fas), which triggered caspase-8 activation following tBid cleavage. Moreover, tBid mediated ROS generation, which triggered mitochondrial dysfunction and activated the mitochondrial apoptotic events. Astrakurkurol cytotoxicity was based on caspase-8-mediated intrinsic apoptotic pathway and was associated with inhibition at Akt and NF-κB pathway. Astrakurkurol had also inhibited the migration of Hep3B cells, indicating its antimigratory potential. These findings led us to introduce astrakurkurol as a feasible and natural source for a safer cytotoxic drug against hepatocellular carcinoma.
Collapse
Affiliation(s)
- Sudeshna Nandi
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| | - Swarnendu Chandra
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| | - Rimpa Sikder
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| | - Saurav Bhattacharya
- Centre for Research in Nanoscience and Nanotechnology , University of Calcutta , JD-2, Sector III, Salt Lake , Kolkata , WB 700098 , India
| | - Manisha Ahir
- Centre for Research in Nanoscience and Nanotechnology , University of Calcutta , JD-2, Sector III, Salt Lake , Kolkata , WB 700098 , India
| | - Debanjana Biswal
- Department of Chemistry , University College of Science , 92, Acharya Prafulla Chandra Road , Kolkata , WB 700009 , India
| | - Arghya Adhikary
- Centre for Research in Nanoscience and Nanotechnology , University of Calcutta , JD-2, Sector III, Salt Lake , Kolkata , WB 700098 , India
| | - Nikhil Ranjan Pramanik
- Department of Chemistry , Bidhannagar College , EB-2, Salt lake , Kolkata 700064 , India
| | - Tapan Kumar Lai
- Department of Chemistry , Vidyasagar Evening College , 39, Sankar Ghosh Lane , Kolkata 700006 , India
| | - Michael G B Drew
- Department of Chemistry , University of Reading , Whiteknights, Reading RG6 6AD , United Kingdom
| | - Krishnendu Acharya
- Molecular and Applied Mycology and Plant Pathology Laboratory, Department of Botany , University of Calcutta , 35, Ballygunge Circular Road , Kolkata , WB 700019 , India
| |
Collapse
|
5
|
Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Naunyn Schmiedebergs Arch Pharmacol 2018; 391:1399-1410. [PMID: 30155693 DOI: 10.1007/s00210-018-1557-6] [Citation(s) in RCA: 30] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2018] [Accepted: 08/15/2018] [Indexed: 12/13/2022]
Abstract
Hepatocellular carcinoma (HCC) is still a leading cancer killer in the community. Molecular targeted therapy with celecoxib (CXB) has shown promising antitumor effects; however, its use may be limited due to serious side effects. Curcumin (CUR) has also shown beneficial effects against HCC. Then, it was aimed to investigate the effects of adding CUR to CXB on HCC HepG2 cells. HepG2 cells were treated with CXB and/or CUR at increasing concentrations to investigate synergistic drug interactions, as calculated combination index (CI). Combination treatment effects on cell viability and caspase-3 activation were assessed. The levels of Akt, nuclear factor-kappa B (NF-κB), prostaglandin E2 (PGE2), malondialdehyde (MDA), cyclin D1 (CD1), and vascular endothelial growth factor (VEGF) were also evaluated. CXB (3.13-100 μM) and/or CUR (1.25-40 μM) reduced HepG2 cell viability dose-dependently. Nevertheless, lower combined concentrations showed higher synergism (CI < 1) and higher CXB dose reduction index (DRI > 1). Also, the addition of CUR to CXB resulted in increased cytotoxicity and caspase-3 activation, as compared to CXB alone. In addition, the selected combination significantly reduced the levels of Akt, NF-κB, PGE2, MDA, CD1, and VEGF, as compared to either agent alone. In conclusion, CUR augmented the CXB-mediated antitumor effects in HepG2 cells through, at least in part, antiproliferative, antioxidant, and pro-apoptotic mechanisms. This may allow the further use of CXB at lower concentrations, combined with CUR, as a promising safer targeted strategy for HCC management.
Collapse
|